Diagnosis begins with a clinical exam. The physician performs an exam using his hands which is similar to the recommended self-exam for all women over 19. Cancerous lumps typically feel hard and don't move around like benign cysts. Cancer tumors usually have an irregular shape, while non cancerous lumps are round. Professionals are trained to distinguish the difference.
A mammogram assists in confirmation of the diagnosis. Modern digital mammograms typically rely on computer assistance. Detection of tumors is aided by complex algorithms that do a great job telling the difference between normal and suspect image sections. This tool greatly assists physicians in eliminating false positives and also helps in detecting smaller, less obvious issues in the early developmental stages.
Ultrasound technology is another modern method that has also been improved upon since its introduction. Ultrasounds are great in helping to distinguish between cysts that are benign and tumors that are cancerous. Because cysts are harmless fluid filled sacs they have a different reaction to sound waves than cancer cells which are much harder and denser.
Magnetic Resonance Imaging, also known as MRI is another useful diagnostic tool and is beginning to be used more often. Years ago, insurance companies wouldn't pay for this extremely expensive test. But since the costs have lowered and the coverage has expanded it is becoming more common. When a powerful magnetic field is swept across the breast it excites molecules in a way that is harmless but produces extremely one of kind results. These results allow professionals to utilize the images that are generated from the MRI to detect very small anomalies.
When other tests make professionals feel that a closer look is needed a biopsy is performed on the cells in question. Some may be as simple as a fine-needle aspiration where a small amount of fluid is removed with a needle from the breast lump in question. That fluid is then examined for cells that are indicative of cancer.
A deeper, or core biopsy is sometimes in order for certain cases. This too uses a needle but one that is thicker and removes tissue. More tissue is removed in a surgical biopsy. The sample is examined by an oncologist who is looking for cancerous cells.
A new test developed at John Hopkins offers promise for even more accurate early diagnosis. Called a QM-MSP (quantitative multiplex methylation-specific PCR), it relies on fluid drawn from the breast. That fluid is then chemically analyzed. When abnormally high levels of certain molecules are detected it indicates the presence of cancer cells. Some studies suggest that clusters with as few as 50 cancer cells can be detected in this way. It was able to detect cancer in 84% of breast tumor samples used.
Utilizing modern techniques and tests, diagnosis can be done in the early cancer stages with much better reliability than in the past. This is necessary in treating breast cancer at the earliest possible stage. Early treatment greatly improves the odds of keeping it from becoming a more serious issue than necessary.
Those of you who have followed our timely reports on hepatitis c know that we endeavor to bring you updated information about new approaches to the treatment and diagnosis of this dreadful virus. As the baby-boomer generation ages, more and more people are now finding out that they have acquired the hepatitis c virus. Many do not know when or how they got the virus, but most people still want sensible and minimally invasive treatments to help them overcome much of the damage caused by the hepatitis c virus.
You already know that one of the tests recommended by hepatologists is the liver biopsy. A liver biopsy is the taking of a small sample of liver tissue which is extracted usually with a needle and examined under a microscope. For many years, this method has been considered by hepatologists as the gold standard for gauging the extent of liver damage in people with chronic hepatitis.
Of course, liver biopsies are not without complications and many people with hepatitis c are reluctant to undergo the procedure. There can be pain involved; drug users in particular may legitimately fear that they will not get adequate pain medication. In addition, liver biopsies are contra-indicated for some people (for example, people with low platelet counts). Furthermore, biopsy complications can occur, including excessive bleeding and infection. And even under the best of circumstances, biopsies fail to accurately diagnose the stage of liver fibrosis about 20% of the time. Thus, researchers have sought other markers that could signal liver damage without the need for biopsy.
In our first report, we told you about the availability of HCV FIBROSURE, a non-invasive blood test for assessing liver status in hepatitis C virus patients. Developed in France, HCV Fibrosure is only available in the United States through LabCorp. But now, two recent Mayo Clinic studies have found that magnetic resonance elastography (MRE), a new imaging technique invented at Mayo Clinic, is an accurate tool for non-invasive diagnosis of liver diseases.
Here’s how MRE works. The liver responds to many diseases that damage its cells by developing scar tissue or fibrosis. MRE uses a modified form of magnetic resonance imaging (MRI) to accurately measure the hardness or elasticity of the liver. By applying vibrations to the liver, MRE obtains pictures of the mechanical waves passing through the organ. The wave pictures are then processed to generate a quantitative image of tissue stiffness. "Healthy liver tissue is very soft, while a liver with fibrosis is firmer, and a liver with cirrhosis is almost rock-hard," says Richard Ehman, M.D., lead researcher on the MRE project. "If detected early, fibrosis of the liver can be treated, but once the disease has progressed to cirrhosis, the condition is irreversible."
In one study involving MRE examinations of 57 individuals with chronic liver disease and 20 healthy volunteers, the researchers confirmed that MRE accurately detects fibrosis with high sensitivity and specificity.
A second study looked at whether MRE can accurately measure portal hypertension, or high blood pressure in the portal vein that carries blood from the digestive track to the liver, usually as a result of cirrhosis of the liver. This study involved 35 individuals with varying degrees of chronic liver disease and 12 healthy volunteers. Researchers studied MRE examinations of liver and spleen stiffness and found that a highly significant correlation exists between liver and spleen stiffness in patients with portal hypertension. However, the validity of spleen stiffness as a noninvasive measure of portal venous pressure requires further study.
This research was funded in part by the National Institutes of Health. Co-authors of these studies include Meng Yin; Roger Grimm; Phillip Rossman; Armando Manduca, Ph.D.; Patrick Kamath, M.D. and Dr. Ehman; all from Mayo Clinic's campus in Rochester; and Anthony Romano, Ph.D., of the Naval Research Laboratory in Washington, D.C.
Most of the people who are afraid of the liver biopsy are the same people who shutter at the thought of having to take interferon chemotherapy. Many others have undergone the interferon treatment and have relapsed. Now they are looking for an alternative way with relatively no side-effects, because they swear they will NEVER undergo interferon treatment again.
For those who do not already know us by name, we are Samglo Enterprises LTD, and we are the makers of Nu-Liver herbal remedy for hepatitis C.
The Chinese people cannot afford the cost of biopsy or interferon treatment. Perhaps this is a blessing in disguise. They have, instead, followed a course of herbal therapy that extends well over 5,000 years. Because of the huge amount of time the Chinese have spent treating individuals with herbs, we have to now assume that the Chinese have gotten very good using herbs and herbal treatments.
And so they have. Presently, over 1 million Chinese individuals are taking the Nu-Liver formulation for their hepatitis C liver disease. Science is continuing to evolve and better and safer methods are hopefully just around the corner. But we must be alive in order to receive these new scientific findings. That is our purpose at Samglo Enterprises: to keep you alive, to keep the hepatitis c virus from doing further harm to your liver, so that when science catches up with the virus, you will be there to receive the newer treatments.
We want you ALIVE, and functioning normally until that time comes. We will not accept treatments that are worse than the disease itself, that destroy the host in an attempt to kill the virus. Until there are safer, more practical, economical, and side-effect free western treatments to cure hepatitis c, we believe that NU-LIVER is the best eastern treatment, virtually side-effect free remedy in today’s marketplace. The Chinese must be doing something right. We are thankful to the Chinese Medical Doctor who brought Nu-Liver to the United States, and also to the tens of thousands of Americans, Europeans, and Australians,who currently take Nu-Liver for their hepatitis C.
As always, we wish you the Best of Health.
Jack Bloom for: www.hepatitisc-remedy.com www.nu-liver.com
Both Www.thealternativecancertreatment.com & Jack Bloom are contributors for EditorialToday. The above articles have been edited for relevancy and timeliness. All write-ups, reviews, tips and guides published by EditorialToday.com and its partners or affiliates are for informational purposes only. They should not be used for any legal or any other type of advice. We do not endorse any author, contributor, writer or article posted by our team.
Www.thealternativecancertreatment.com has sinced written about articles on various topics from Types of Cancer. Can there really be a natural way to fight cancer cell ? Yes, fucoidan, was proven scientifically to do just that. The essence of brown seaweed Visit my site at. Www.thealternativecancertreatment.com's top article generates over 12100 views. Bookmark Www.thealternativecancertreatment.com to your Favourites.
Jack Bloom has sinced written about articles on various topics from Types of Cancer. http://www.hepatitisc-remedy.com. Jack Bloom's top article generates over 5400 views. Bookmark Jack Bloom to your Favourites.